Constant Illumination Induces Alzheimer-Like Damages with Endoplasmic Reticulum Involvement and the Protection of Melatonin

被引:57
作者
Ling, Zhi-Qun [1 ,2 ]
Tian, Qing [1 ]
Wang, Li [1 ]
Fu, Zheng-Qi [1 ]
Wang, Xiao-Chuan [1 ]
Wang, Qun [1 ]
Wang, Jian-Zhi [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Neurol Dis Natl Educ Minist & Hubei Prov, Dept Pathol & Pathophysiol, Wuhan 430030, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu, Peoples R China
关键词
Alzheimer's disease; endoplasmic reticulum stress; light illumination; melatonin; tau; GLYCOGEN-SYNTHASE KINASE-3; N-TERMINAL KINASE; PHOSPHORYLATES TAU-PROTEIN; SPATIAL MEMORY RETENTION; RAT-BRAIN; OXIDATIVE STRESS; TRANSGENIC MICE; OKADAIC ACID; MOUSE MODEL; A-BETA;
D O I
10.3233/JAD-2009-0949
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Most patients with Alzheimer's disease (AD) present decreased levels of melatonin, a day-night rhythm-related hormone. To investigate the role of melatonin deficiency in AD, we used constant illumination to interrupt melatonin metabolism and measured some of the AD-like alterations in rats. Concomitant with decreased serum melatonin, the rats developed spatial memory deficits, tau hyperphosphorylation at multiple sites, activation of glycogen synthase kinase-3 and protein kinase A, as well as suppression of protein phosphatase-1. Prominent oxidative damage and organelle lesions, demonstrated by increased expression of endoplasmic reticulum (ER) stress-related proteins including BiP/GRP78 and CHOP/GADD153, decreased number of rough ER and free ribosome, thinner synapses, and increased superoxide dismutase and monoamine oxidase were also observed in the light exposed rats. Simultaneous supplement of melatonin partially arrested the behavioral and molecular impairments. It is suggested that melatonin deficiency may be an upstream effector responsible for the AD-like behavioral and molecular pathologies with ER stress-involved mechanisms.
引用
收藏
页码:287 / 300
页数:14
相关论文
共 82 条
[21]   Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice [J].
Halverson, RA ;
Lewis, J ;
Frausto, S ;
Hutton, M ;
Muma, NA .
JOURNAL OF NEUROSCIENCE, 2005, 25 (05) :1226-1233
[22]   Suppression of melatonin by 2000-lux light in humans with closed eyelids [J].
Hätönen, T ;
Alila-Johansson, A ;
Mustanoja, S ;
Laakso, ML .
BIOLOGICAL PSYCHIATRY, 1999, 46 (06) :827-831
[23]   p38 kinase is activated in the Alzheimer's disease brain [J].
Hensley, K ;
Floyd, RA ;
Zheng, NY ;
Nael, R ;
Robinson, KA ;
Nguyen, X ;
Pye, QN ;
Stewart, CA ;
Geddes, J ;
Markesbery, WR ;
Patel, E ;
Johnson, GVW ;
Bing, GY .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) :2053-2058
[24]   Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments [J].
Hernández, F ;
Borrell, J ;
Guaza, C ;
Avila, J ;
Lucas, JJ .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (06) :1529-1533
[25]  
Ito T, 1999, Nihon Ika Daigaku Zasshi, V66, P229, DOI 10.1272/jnms.66.229
[26]   VISUALIZATION OF A-BETA-42(43) AND A-BETA-40 IN SENILE PLAQUES WITH END-SPECIFIC A-BETA MONOCLONALS - EVIDENCE THAT AN INITIALLY DEPOSITED SPECIES IS A-BETA-42(43) [J].
IWATSUBO, T ;
ODAKA, A ;
SUZUKI, N ;
MIZUSAWA, H ;
NUKINA, N ;
IHARA, Y .
NEURON, 1994, 13 (01) :45-53
[27]   Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats [J].
Jahnke, G ;
Marr, M ;
Myers, C ;
Wilson, R ;
Travlos, G ;
Price, C .
TOXICOLOGICAL SCIENCES, 1999, 50 (02) :271-279
[28]   IMMEDIATE RESPONSE TO LIGHT OF RAT PINEAL MELATONIN RHYTHM - ANALYSIS BY IN-VIVO MICRODIALYSIS [J].
KANEMATSU, N ;
HONMA, S ;
KATSUNO, Y ;
HONMA, KI .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :R1849-R1855
[29]   Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease [J].
Kennedy, BP ;
Ziegler, MG ;
Alford, M ;
Hansen, LA ;
Thal, LJ ;
Masliah, E .
JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (07) :789-801
[30]   Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3 [J].
Kim, AJ ;
Shi, YY ;
Austin, RC ;
Werstuck, GH .
JOURNAL OF CELL SCIENCE, 2005, 118 (01) :89-99